Modulatory effects of L-DOPA on D2 dopamine receptors in rat striatum, measured using in vivo microdialysis and PET

Journal of Neural Transmission

Volumn 105, Issue 4-5, 1998, Pages 349-364

  Opacka Juffry, J ^b   Ashworth, S ^a,b   Ahier, R G ^b,c   Hume, S P ^b  

^a DMPK   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Chronic L DOPA; GABA; Globus pallidus; Glutamate

Indexed keywords

3 HYDROXYBENZYLHYDRAZINE; 4 AMINOBUTYRIC ACID; CARBIDOPA; DOPAMINE; DOPAMINE 2 RECEPTOR; LEVODOPA; RACLOPRIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; GLOBUS PALLIDUS; HABITUATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MICRODIALYSIS; NONHUMAN; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; RECEPTOR SENSITIVITY;

ANIMALS; CARBIDOPA; CARBON RADIOISOTOPES; CORPUS STRIATUM; DOPA DECARBOXYLASE; DOPAMINE; ENZYME INHIBITORS; GAMMA-AMINOBUTYRIC ACID; GLOBUS PALLIDUS; HYDRAZINES; KINETICS; LEVODOPA; MALE; MICRODIALYSIS; RACLOPRIDE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2; SALICYLAMIDES; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0031881101     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007020050063     Document Type: Article

References (41)

1. Bloomfield PM, Rajeswaran S, Spinks TJ, Hume SP, Myers R, Ashworth S, Clifford KM, Jones WF, Byars LG, Young J, Andreaco M, Williams CW, Lammertsma AA, Jones T (1995) The design and physical characteristics of a small animal positron emission tomograph. Phys Med Biol 40: 1105-1126
2. 2 dopamine receptors in 6-OHDA-lesioned rats receiving foetal ventral mesencephalic grafts and chronic treatment with L-DOPA and carbidopa. Brain Res 582: 299-311
3. Bourdelais AJ, Kalivas PW (1993) Modulation of extracellular gamma-aminobutyric acid in the ventral pallidum using in vivo microdialysis. J Neurochem 58: 2311-2320
4. Calabresi P, De Murtas M, Mercuri NB, Bernardi GB (1992) Chronic neuroleptic treatment: D2 dopamine receptor supersensitivity and striatal glutamatergic transmission. Ann Neurol 31: 366-373
5. Campbell K, Kalén P, Lundberg C, Wictorin K, Rosengren E, Björklund A (1993) Extracellular gamma-aminobutyric acid levels in the rat caudate-putamen: monitoring the neuronal and glial contribution by intracerebral microdialysis. Brain Res 614: 241-250
6. Daly DR, Moghaddam B (1993) Actions of clozapine and haloperidol on the extracellular levels of excitatory amino acids in the prefrontal cortex and striatum of concious rats. Neurosci Lett 152: 61-64
7. 11C-raclopride is altered by drugs that modify synaptic dopamine levels. Synapse 13: 350-356
8. 2-dopamine receptors by PET. Psychopharmacology 94: 471-478
9. Fisher RS, Levine MS, Sibley DR, Ariano MA (1994) D-2 dopamine receptor protein location: Golgi impregnation-gold toned and ultrastructural analysis of the rat neostriatum. J Neurosci Res 38: 551-564
10. Gerfen CR (1992) The neostriatal mosaic: multiple levels of compartmental organization in the basal ganglia. Ann Rev Neurosci 15: 285-320
11. Hume SP, Myers R, Bloomfield PM, Opacka-Juffry J, Cremer JE, Ahier RG, Luthra SK, Brooks DJ, Lammertsma AA (1992) Quantitation of carbon-11 labeled raclopride in rat striatum using positron emission tomography. Synapse 12: 47-54
12. 11C]raclopride binding in rat striatum, quantified using PET. Synapse 21: 45-53
13. Hume SP, Lammertsma AA, Myers R, Rajeswaran S, Bloomfield PM, Ashworth S, Fricker RA, Torres EM, Watson I, Jones T (1996) The potential of high-resolution positron emission tomography to monitor striatal dopaminergic function in rat models of disease. J Neurosci Methods 67: 103-112
14. Hutson PH, Sarna GS, Sahakian BJ, Dourish CT, Curzon G (1986) Monitoring of 5-HT metabolism in the brain of the freely moving rat. Ann NY Acad Sci 473: 321-336
15. Jackson DM, Jenkins OF, Malor R, Christie MJ, Gregory P (1983) Chronic L-DOPA treatment of rats and mice does not change the sensitivity of post-synaptic dopamine receptors. Arch Pharmacol 324: 271-274
16. Jenner P, Marsden CD (1987) Chronic pharmacological manipulation of dopamine receptors in brain. Neuropharmacology 26: 931-940
17. Jian M, Staines WA, Iadarola MJ, Robertson GS (1993) Destruction of the nigrostriatal pathway increases Fos-like immunoreactivity predominantly in striatopallidal neurones. Mol Brain Res 19: 156-160
18. Kita H, Kitai ST (1988) Glutamate decarboxylase immunoreactive neurons in rat neostriatum: their morphological types and populations. Brain Res 447: 346-352
19. Levey AI, Herch SM, Rye DB, Sunahara R, Niznik HB, Kitt CA, Price DL, Maggio R, Brann MR, Ciliax BJ (1993) Localization of D1 and D2 dopamine receptors in rat, monkey, and human brain with subtype-specific antibodies. Proc Natl Acad Sci 90: 8861-8865
20. Linderfors N (1993) Dopaminergic regulation of glutamic acid decarboxylase mRNA expression and GABA release in the striatum: a review. Prog Neuropsychopharmacol Biol Psychiatry 17: 887-903
21. Marsden CD, Parkes JD (1977) Success and problems of long-term levodopa therapy in Parkinson's disease. Lancet i: 345-349
22. 3H]-glutamic acid release by dopaminergic drugs. Life Sci 26: 2073-2081
23. Misu Y, Goshima Y (1993) Is L-DOPA an endogenous neurotransmitter? TIPS 14: 119-123
24. Morris ED, London ED (1997) Limitations of binding potentials as a "clinical" measure of receptor function: susceptibility to mass. NeuroImage 5: B61
25. Murata M, Kanazawa I (1993) Repeated L-DOPA administration reduces the ability of dopamine storage. Neurosci Res 16: 15-23
26. Opacka-Juffry J, Brooks DJ (1995) L-Dihydroxyphenylalanine and its decarboxylase: new ideas on their neuroregulatory roles. Mov Disord 10: 241-249
27. Opacka-Juffry J, Ahier RG, Cremer JE (1991) Nomifensine-induced increase in extracellular striatal dopamine is enhanced by isoflurane anaesthesia. Synapse 7: 169-171
28. Parenti M, Flauto C, Parati E, Vescovi A, Groppetti A (1986) Differential effects of repeated treatment with L-DOPA on dopamine-D1 or -D2 receptors. Neuropharmacology 25: 331-334
29. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates. Academic Press, London
30. Reches A, Wagner HR, Jiang D-H, Jackson V, Fahn S (1982) The effect of chronic L-DOPA administration on supersensitive pre-and postsynaptic dopaminergic receptors in rat brain. Life Sci 31: 37-44
31. Reches A, Wagner HR, Jackson-Lewis V, Yablonskaya-Alter E, Fahn S (1984) Chronic levodopa or pergolide administration induces down regulation of dopamine receptors in denervated striatum. Neurology 34: 1208-1212
32. Robb RA, Hanson DP (1991) A software system for interactive and quantitative visualization of multidimensional biomedical images. Australas Phys Eng Sci Med 14: 9-30
33. Rouillard C, Bedard PJ, Falardeau P, Dipaolo T (1987) Behavioural and biochemical evidence for a different effect of repeated administration of L-DOPA and bromocriptine on denervated versus non-denervated striatal dopamine receptors. Neuropharmacology 26: 1601-1606
34. Scheel-Krüger J (1986) Dopamine-GABA interactions: evidence that GABA transmits. modulates and mediates dopaminergic functions in the basal ganglia and the limbic system. Acta Neurol Scand [Suppl] 73: 1-54
35. Schneider MB, Murrin LC, Pfeiffer RF, Deupree JD (1984) Dopamine receptors: effects of chronic L-DOPA and bromocriptine treatment in an animal model of Parkinson's disease. Clin Neuropharmacol 7: 247-257
36. 3H] raclopride: implications for positron emission tomography of the human brain. Synapse 3: 96-97
37. Sesack SR, Aoki C, Pickel VM (1994) Ultrastructural localization of D2 receptor-like immunoreactivity in midbrain dopamine neurons and their striatal targets. J Neurosci 14: 88-106
38. Tedroff J, Torstenson R, Hartvig P, Lindner KJ, Watanabe Y, Bjurling P, Westerberg G, Långström (1997) L-DOPA modulates striatal dopaminergic function in vivo: evidence from PET investigations in nonhuman primates. Synapse 25: 56-61
39. 11C]raclopride in the human brain. Synapse 16: 255-264
40. Wilner KD, Butler IJ, Seifert WE, Clement-Cormier YC (1980) Biochemical alterations of dopamine responses following chronic L-DOPA therapy. Biochem Pharmacol 29: 701-706
41. Yamamoto BK, Davy S (1992) Dopaminergic modulation of glutamate release in striatum as measured by microdialysis. J Neurochem 58: 1736-1742